Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 8,000 shares, a growth of 300.0% from the October 31st total of 2,000 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 18,100 shares, the short-interest ratio is currently 0.4 days.

Cocrystal Pharma Price Performance

Shares of COCP traded down $0.02 on Wednesday, hitting $2.10. The company’s stock had a trading volume of 6,018 shares, compared to its average volume of 21,091. The company has a market capitalization of $21.36 million, a PE ratio of -1.15 and a beta of 1.45. Cocrystal Pharma has a fifty-two week low of $1.33 and a fifty-two week high of $3.10. The company has a 50 day moving average price of $1.88 and a 200 day moving average price of $2.03.

Analyst Upgrades and Downgrades

Separately, HC Wainwright dropped their price objective on Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, August 22nd.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.